D003550DisordersC06.689.202C08.381.187C16.320.190C16.614.21312180.974123Cystic Fibrosiscmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson3Assistant Professor2Associate Professor1ProfessorPhD, BVSc, DABMM, FIDSA, FAAMRangarajSelvaranganRangaraj Selvarangan0.000000000000000.00000000000000126Selvarangan, Rangaraj0000-0003-3275-6657Director of Clinical Microbiology and VirologyPhDMeredithDreyer GilletteMeredith L. Dreyer Gillette0.000000000000000.00000000000000130Dreyer Gillette, MeredithClinical Psychologist, Center for Children's Healthy Lifestyles & NutritionPathologyPathology and Laboratory MedicinePediatricsMedical SchoolResearchClinicalChildren's Mercy Kansas CityPhD, MVScNeenaKanwarNeena Kanwar0.000000000000000.00000000000000178Kanwar, Neena0000-0002-3923-2453Research Scientist PhDMDHugoEscobarHugo Escobar0.000000000000000.00000000000000202Escobar, HugoAssociate Professor of PediatricsPulmonary and Sleep MedicineMDZarminaEhsanZarmina Ehsan0.000000000000000.00000000000000208Ehsan, ZarminaPhysician Sleep Center Pulmonogy26573178Ehsan Z, Clancy JPFuture microbiologyEhsan Z, Clancy JP. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin. Future Microbiol. 2015; 10(12):1901-12.Future Microbiol2015-11-17T00:00:002015Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.31018133Jorth P, Ehsan Z, Rezayat A, Caldwell E, Pope C, Brewington JJ, Goss CH, Benscoter D, Clancy JP, Singh PKCell reportsJorth P, Ehsan Z, Rezayat A, Caldwell E, Pope C, Brewington JJ, Goss CH, Benscoter D, Clancy JP, Singh PK. Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis. Cell Rep. 2019 04 23; 27(4):1190-1204.e3.Cell Rep2019-04-23T00:00:002019Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis.30334693Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SMThe New England journal of medicineDavies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM. VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med. 2018 10 25; 379(17):1599-1611.N Engl J Med2018-10-18T00:00:002018VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.34706982Nichols DP, Singh PK, Baines A, Caverly LJ, Chmiel JF, GIbson RL, Lascano J, Morgan SJ, Retsch-Bogart G, Saiman L, Sadeghi H, Billings JL, Heltshe SL, Kirby S, Kong A, Nick JA, Mayer-Hamblett NThoraxNichols DP, Singh PK, Baines A, Caverly LJ, Chmiel JF, GIbson RL, Lascano J, Morgan SJ, Retsch-Bogart G, Saiman L, Sadeghi H, Billings JL, Heltshe SL, Kirby S, Kong A, Nick JA, Mayer-Hamblett N. Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax. 2022 06; 77(6):581-588.Thorax2021-10-27T00:00:002021Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.36806840Kanwar N, Harrison CJ, Pence MA, Qin X, Selvarangan RDiagnostic microbiology and infectious diseaseKanwar N, Harrison CJ, Pence MA, Qin X, Selvarangan R. Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis. Diagn Microbiol Infect Dis. 2023 Apr; 105(4):115904.Diagn Microbiol Infect Dis2023-01-26T00:00:002023Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis.true1Research Scientist PhDResearch Scientist PhDtrue1Director of Clinical Microbiology and VirologyDirector of Clinical Microbiology and Virologytrue1Clinical Psychologist, Center for Children's Healthy Lifestyles & NutritionClinical Psychologist, Center for Children's Healthy Lifestyles & Nutritiontrue1Associate Professor of PediatricsAssociate Professor of Pediatricstrue1Physician Sleep Center PulmonogyPhysician Sleep Center Pulmonogy1.204250.033819312research area of0.9226880.028531919subject area for